RT Book, Section
A1 Schoos, Mikkel Malby
A1 Mehran, Roxana
A1 Dangas, George
A2 Samady, Habib
A2 Fearon, William F.
A2 Yeung, Alan C.
A2 King III, Spencer B.
SR Print(0)
ID 1146605804
T1 Bleeding Risk Scores
T2 Interventional Cardiology, 2e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9780071820363
LK accesscardiology.mhmedical.com/content.aspx?aid=1146605804
RD 2024/04/24
AB Advances  in  the  catheterizations  techniques,  stent  designs,  and  pharmacotherapeutics  have  reduced  adverse  ischemic  event  rates  such  as  cardiovascular  death,  ST  (stent  thrombosis),  recurrent  myocardial  infarctions,  and  revascularizations  in  patients  with  coronary  artery  disease  undergoing  elective  or  acute  percutaneous  coronary  intervention  (PCI).  However,  the  same  antithrombotic  regimens  also  increase  bleeding  risk,  and  a  cornerstone  of  contemporary  cardiovascular  interventions  is  balancing  ischemic  and  bleeding  events  in  order  to  optimize  the  net  benefit  for  the  individual  patient.